Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

New neuroleptic agents reported by Ferrer

Dec. 10, 1996

Novo Nordisk claims dopamine D3 receptor ligands for CNS indications

Dec. 9, 1996

New analgesic compounds with novel mechanism of action disclosed by Novo Nordisk

Dec. 6, 1996

New therapeutic approach to neurogenerative disorders

Dec. 4, 1996

JT discloses new compounds for Alzheimer's disease and other CNS disorders

Dec. 4, 1996

New 5-HT1D antagonists from SmithKline Beecham

Dec. 4, 1996

McNeil describes new antipsychotic compounds

Dec. 4, 1996

Avonex progresses toward European approval

Dec. 3, 1996

New hope for muscular dystrophy sufferers

Dec. 3, 1996

Antiepileptic drug from Neurogen licensed to Wyeth-Ayerst

Dec. 2, 1996

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...